Form D · Other Technology

WhisperSom Medical Technologies, Inc

Annapolis, MD · CIK 0001664437

Offering snapshot reported Jun 17, 2026 · SEC filing

Reported sold
$364K
Offering amount: $3.5M
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 24, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 17, 2026Initial$364,000No comparison11SEC filing
Oct 12, 2022Initial$525,000No comparison6SEC filing
Dec 30, 2020Initial$100,000No comparison1SEC filing
Jan 24, 2019Initial$50,000No comparison1SEC filing
Nov 6, 2018Initial$30,000No comparison1SEC filing
Jul 6, 2017Initial$200,000No comparison1SEC filing
Feb 1, 2016Initial$20,000No comparison1SEC filing
Feb 1, 2016Initial$30,000No comparison3SEC filing

Offering details

Securities
Equity, Other
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-587732
Series A-1 Preferred Stock

Source: Form D, filed Jun 17, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jason Boling Executive
Craig Feied Director, Executive
David Glodstein Director
David Goldstein Director
Kevin F. Goldstein Executive
William A. Headapohl Director
Michael Nathans Director, Executive
Headapohl William Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
1997 Annapolis Exchange Parkway Suite 300
Annapolis, MD, 21401